Chee, L., Tan, S., Valcárcel, D., Puliyayil, A., Arbelaez, A., Arnan, M., Ross, D., Hiwase, D., Bernal, T., Cluzeau, T., Giagounidis, A., Salstrom, J., Ramesh, R., Bay, C., Galinsky, K., Sellner, L., Suryanarayan, K., Diez-Campelo, M. (2025). Elritercept shows durable responses in lower-risk myelodysplastic neoplasms (LR-MDS) with transfusion dependence: Updated Results from an ongoing Phase 2 trial. Blood. https://doi.org/10.1182/blood-2025-787